The Global Adaptogenic Mushrooms Market size is expected to reach $20.1 billion by 2028, rising at a market growth of 9.9% CAGR during the forecast period.
Adaptogenic mushroom describes mushroom varieties with special health benefits and nutritional value. These mushrooms can contribute to well-being and health by enhancing cognitive function, reducing stress, and increasing energy levels. In addition, they have anti-inflammatory characteristics and give a high number of antioxidants to increase energy and blood flow in the body and aid in stress management.
These mushrooms are nutrient-dense and include high levels of fiber, protein, and vitamins and sufficient amounts of proteins, lipids, enzymes, essential oils such as triterpenes, and polysaccharides beta-glucans, which is driving sales of functional mushrooms. Adaptogens are plants and fungi that assist the body in responding to stress, anxiety, exhaustion, and overall health. Adaptogens can be consumed by adding them to food or beverages, brewing them into tea, or swallowing them in capsule form.
Adaptogens restore the body's equilibrium by regulating mental and physical stressors, enhancing the body's resistance to the detrimental effects of stress, and promoting or restoring normal physiological functioning. In addition, it helps the body deal with stress, worry, and exhaustion. Adaptogen is intended to supply the herb that helps the body regulate its natural metabolism and attain equilibrium. It reduces psychological stress.
Adaptogens are available in various forms, including adaptogen teas, adaptogen powder that can be taken with food, and capsules. The primary factors driving the expansion of the adaptogenic mushroom market size are the increasing stress levels of consumers worldwide. The market expansion is propelled by consumers' growing interest in natural health cures and their growing understanding of mushrooms' health advantages. Moreover, the growing levels of consumer stress are a significant element driving market demand.
The rising prevalence of diseases caused by meat and junk food is one of the most prevalent causes of veganism and increased awareness of the health benefits of a vegan diet. Thus, with the spread of COVID-19, consumers have increased their desire for vegan foods, such as adaptogenic mushrooms, which help them develop immunity and combat the virus. Thus, the demand for therapeutic mushroom-based foods and supplements is increasing. As a result, the market for adaptogenic mushrooms is growing, as they offer the body all the nutrients it needs to function properly.
The rise of the market for adaptogenic mushrooms is stimulated by the fact that functional molecules from mushrooms improve patients' quality of life on lifelong treatment drugs. Moreover, functional mushrooms can boost other treatments and complement contemporary therapy when used as medication. The increasing preference for using natural goods, like functional mushrooms, in conventional therapies is driving market expansion. In addition, ongoing research into the bioactive metabolites of mushrooms is anticipated to expedite the use of adaptogenic mushrooms in medicinal applications for the foreseeable future.
Innovations for creating new gourmet dishes employing adaptogenic mushrooms and the rising demand for high-quality food products are driving market expansion. The expansion of distribution channels and the increasing availability of functional mushrooms via e-commerce portals are major factors in the market's expansion. Furthermore, growing government efforts to encourage mushroom cultivation and meet rising demand provide additional impetus for market expansion. In addition, the increasing penetration of market participants and the expansion of the distribution of high-quality mushrooms are anticipated to be important market drivers for adaptogenic mushrooms over the coming years.
Since medicinal mushrooms are a relatively new trend, many dietitians did not obtain much education or training on the topic. Another major obstacle is sourcing; many therapeutic mushrooms cannot be taken in their natural, unprocessed form, so processing is required. However, many of these mushrooms are supplied from foreign countries, which may raise environmental and pesticide safety concerns. Hence, the lack of study conducted on these mushrooms, which causes consumers to seek out information about the product on their own, and worries surrounding the quality of the raw product, may restrain market expansion.
Based on product, the adaptogenic mushrooms market is segmented into reishi, chaga, turkey tail, lion’s mane, cordyceps and others. In 2021, the reishi segment held the highest revenue share in the adaptogenic mushrooms market. Reishi's potential health advantages and long-standing use in herbal medicine drive its demand as an adaptogenic fungus. Traditional Chinese medicine has utilized reishi mushrooms to boost immune system health and lengthen life. Reishi, an adaptogenic mushroom, is becoming more well-known in the wellness sector as a natural way to enhance the body's capacity to respond to stress and advance general well-being.
On the basis of application, the adaptogenic mushrooms market is divided into immunity booster, stress & anxiety relief, cognitive, brain support & mental health support, insomnia treatment and others. In 2021, the stress & anxiety relief segment witnessed the largest revenue share in the adaptogenic mushrooms market. The supposed health benefits gained from adaptogenic mushrooms, including regulation of adrenal glands, improvement of oxygen uptake, enhancement of energy levels, and reduction of inflammation, are the primary force behind the segment's demand. Furthermore, the rise in chronic inflammatory cases supports using adaptogenic mushrooms to treat anxiety and stress.
By form, the adaptogenic mushrooms market is classified into fresh/whole, dried and processed. The fresh/whole segment garnered a significant revenue share in the adaptogenic mushrooms market in 2021. The strong demand for nutrient-dense foods and rising consumer awareness of ethically sourced commodities are driving up the price of fresh mushrooms. In addition, the flavor of fresh mushrooms is subtler and more nuanced than dried mushrooms, and it may be more intense and earthier. In the anticipated term, the segment's expansion is anticipated to be aided by the rising demand for nutrient-dense foods and their exquisite flavors.
| Report Attribute | Details |
|---|---|
| Market size value in 2021 | USD 10.5 Billion |
| Market size forecast in 2028 | USD 20.1 Billion |
| Base Year | 2021 |
| Historical Period | 2018 to 2020 |
| Forecast Period | 2022 to 2028 |
| Revenue Growth Rate | CAGR of 9.9% from 2022 to 2028 |
| Number of Pages | 226 |
| Number of Table | 400 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Application, Form, Product, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Region-wise, the adaptogenic mushrooms market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2021, the Asia Pacific region led the adaptogenic mushrooms market by generating the highest revenue share. In recent years, the Asia Pacific region has seen a steady rise in the market for adaptogenic mushrooms. Adaptogenic mushrooms are medicinal fungi used for generations in Asian traditional medicine. They have several health advantages, including reducing stress, supporting the immune system, and reducing inflammation.
Free Valuable Insights: Global Adaptogenic Mushrooms Market size to reach USD 20.1 Billion by 2028
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fungi Perfecti LLC, Sun Potion, Om Mushroom Superfood, Four Sigmatic, Real Mushrooms, Terrasoul Superfoods, JHS Natural Products, Inc. (Mushroom Science), Nammex, Bristol Botanicals Limited, and Annanda Chaga Mushrooms.
By Application
By Form
By Product
By Geography
The global Adaptogenic Mushrooms Market size is expected to reach $20.1 billion by 2028.
Growing demand in pharmaceutical industry are driving the market in coming years, however, Lack of research and concerns regarding raw products’ quality restraints the growth of the market.
Fungi Perfecti LLC, Sun Potion, Om Mushroom Superfood, Four Sigmatic, Real Mushrooms, Terrasoul Superfoods, JHS Natural Products, Inc. (Mushroom Science), Nammex, Bristol Botanicals Limited, and Annanda Chaga Mushrooms.
The Dried segment acquired maximum revenue share in the Global Adaptogenic Mushrooms Market by Form in 2021 thereby, achieving a market value of $11.7 billion by 2028.
The Asia Pacific market dominated the Global Adaptogenic Mushrooms Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8.2 billion by 2028.
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
